Home
Santhera

Santhera Market Share Analysis for May 2026

pharmaceutical company in switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.

Health > Biotechnology and Pharmaceuticals

Domainsanthera.com

Year Founded2004

Employees51 - 200

Annual Revenue$25M - $50M

Santhera

Santhera (including company regionals)

santhera.com

See more website traffic and engagement information

Santhera Revenue up to May 2026 is 25M - 50M

revenue generated by Santhera top domains

Santhera top domains revenue over 3 years

Revenue for Santhera top domains

santhera.com25M - 50M

See more with Sales Intelligence

Santhera Stock price in May 2026

Santhera stock is traded under the ticker #SANN. Below you can review Santhera stock performance in the past 12 months up to May 2026

Total visits to Santhera's top domains

Understand Santhera market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

santhera.com14.9K

See more with Sales Intelligence

Avg. visit duration in Santhera's top domains

Analyze Santhera engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

santhera.com00:00:29

See more with Sales Intelligence

Avg. pageviews on Santhera's top domains

See how Santhera keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

santhera.com1.78

See more with Sales Intelligence

Santhera top competitors by domain

Top similar sites in May 2026, ranked by their affinity

norgine.comCompany NameNorgineEmployees1001 - 5000HQNetherlands, AmsterdamAnnual revenue$200M - $500MTotal visits14.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Santhera

These are the website technologies, by industry, used by Santhera top domains

Payment & Currencies (25)

PayPal

Social (5)

Google+ Platform

Advertising (2)

DoubleClick

Content Management System (2)

Sitefinity

More Technologies

10

See all

News & Signals from Santhera

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBazemore leaves Santhera Pharmaceuticals AG as President of U.S. Operations.Previously, Mr. Bazemore served as President of U.S. Operations at Santhera Pharmaceuticals, a company in late-stage clinical development in rare neuromuscular diseases, and as Chief Commercial Officer at Dyax Corp, a late-clinical-stage and commercial company focused on hereditary angioedema.

NewsSanthera Pharmaceuticals AG attended event Annual General Meeting on May 26th '26.Pratteln, Switzerland, May 26, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln, Switzerland, with a large majority.

NewsSanthera Pharmaceuticals AG will hire Orlando Oliveira as Chief Executive Officer on Jul 15th '26.Pratteln, Switzerland, April 23, 2026 - Santhera Pharmaceuticals (SIX: SANN) announces the appointment of Orlando Oliveira as Chief Executive Officer (CEO), effective July 15, 2026.